quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 24, 2026

Social Security's 2027 COLA Could Be the Biggest Since 2023

View original at nasdaq.com
Social Security's 2027 COLA Could Be the Biggest Since 2023 Key Points Recent developments have pushed expectations for the 2027 COLA significantly higher…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • 62% of retirees say Social Security is a major source of revenue, the highest level recorded in the poll's 25-year history

    60% confidence
  • The longer the Strait of Hormuz remains blocked, the higher oil prices will climb, with a knock-on effect on overall inflation rates

    60% confidence
  • The CPI-W rose 3.9% year over year in April, driven by the ongoing war in Iran pushing oil prices higher

    60% confidence
  • Prices for shelter, medical services, and food all increased about 3.2% year over year, exceeding the 2.8% COLA most beneficiaries received

    60% confidence
  • The 2027 Social Security COLA is now projected at 4.2%, up from prior expectations of 3.2%

    60% confidence
  • Business leaders expect inflation to average 3.7% over the next 12 months, based on the Cleveland Fed's quarterly executive survey

    60% confidence
  • The 2027 COLA could be the highest since the 8.7% adjustment in 2023 and would rank as the third-largest COLA since 2009

    60% confidence
  • CPI-U is forecast to climb 4.2% year over year

    60% confidence
  • The 2027 Social Security COLA is now expected to come in at 3.9%, up from a prior forecast of 2.8%

    60% confidence

Data points we hold from this source

Social Security Administration · market share62 percent_retirees_citing_as_major_income_source
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
A nossa leitura dos dados ›
Sinais que acompanhamos
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,985
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,985 factos verificados com a fonte5,351 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Social Security's 2027 COLA Could Be the Biggest Since 2023 — Source | Via News | pt.VIA.NEWS